Physician profile
Edward Guerrant Lilly
NPI 1689614570
$803.25
in general payments reported to CMS, 2019-2025
16 companies · $62.15 in 2025
The $62.15 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $14.42 · 2021: $115 · 2022: $166 · 2023: $135 · 2024: $198 · 2025: $62.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $395.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $156.34 | 2022-2024 | Penta |
| Sanara Medtech INC. | $114.99 | 2021 | |
| Peerless Surgical INC. | $97.74 | 2023-2024 | |
| Onkos Surgical, INC. | $87.14 | 2024 | Eleos Limb Salvage System |
| Conformis, INC. | $60.71 | 2019 | |
| Heron Therapeutics, INC. | $53.31 | 2023 | Zynrelef |
| Stryker Corporation | $41.67 | 2025 | Clottriever Bold Catheter |
| Biocomposites INC | $41.19 | 2019 | |
| Inari Medical, INC. | $38.06 | 2024-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Solventum Corporation | $23.28 | 2024 | Prevena |
| Becton, Dickinson and Company | $19.89 | 2023 | |
| Amgen INC. | $18.21 | 2022 | |
| Sanofi-Aventis U.S. LLC | $14.42 | 2020 | |
| Convatec INC. | $13.08 | 2023 | |
| Heraeus Medical, LLC. | $11.75 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $11.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Lilly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.